Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 45 for “"cereblon"”.
-
The Development of Cereblon Recruiting BromoTag Degraders for Targeted Protein Degradation
… toolkit via the incorporation of a corresponding Cereblon (CRBN)-recruiting BromoTag degrader. <br/><br/>We sought to design and synthesise a small series of CRBN-recruiting BromoTag degraders and assess their on-target potency and selectivity against the wildtype Bromodomain and Extra-Terminal …
-
Understanding the Role of Cereblon in Hematopoiesis Through Structural and Functional Analyses
… More ground-breaking was the identification of cereblon as the target of IMiD®s. Upon binding to thalidomide and other immunomodulatory drugs, the E3 ligase substrate receptor cereblon (CRBN) promotes proteosomal destruction of neo-substrates by engaging the DDB1-CUL4A-Roc1-RBX1 E3-ubiquitin …
-
An unbiased proteomics approach identifies novel cereblon-engaging immunomodulatory imide molecular glues
… immunomodulatory imide-derived compounds for cereblon-dependent degradation activity. Eight cereblon-binding analogues were synthesized (>95% purity) and six analogues demonstrating adequate solubility and stability for cell-based assays were profiled in Jurkat T-cells alongside lenalidomide …
-
The Effects of GSPT1 Degradation on Serum Calcium, Parathyroid Hormone, and Fibroblast Growth Factor 23 Concentrations in Human Cereblon Knock-in Mice
Test article CC-325 is a potent oral cereblon (CRBN) modulator that has shown potent G1 to S phase transition 1 (GSPT1) degradation and anti-tumor activity in pre-clinical models. One of the adverse effects associated with CC-325 was dose dependent hypocalcemia, which was determined to be an …
-
NOVEL SALL4 DEGRADER FOR CANCER TREATMENT
… cellular assay, and cell viability assay. A new cereblon modulator, QE, was discovered, which effectively depleted SALL4B via proteasomal degradation. QE exhibited significant anti-cancer effects, inhibiting cancer cell viability in culture and in vivo tumor growth by 70% in the HCC xenograft …
-
Discovery of DYR684, a First-in-Class DYRK1A/B PROTAC
… ligands for the E3 ubiquitin ligase component Cereblon (CRBN) to induce ubiquitination and subsequent proteasomal degradation of DYRK1A and DYRK1B. The lead compound (DYR684) promoted fast, efficient, potent, and selective degradation of overexpressed and endogenous DYRK1A in cell-based assays. …
-
Synthesis and biological characterisation of cyclic peptide PROTACs of hypoxia inducible factor 1 alpha
… to recruit either the Von Hippel Lindau (VHL) or Cereblon (CRBN) E3 ligase. Biophysical and cellular assays informed the design of second-generation PROTACs using the optimised cyclic peptide cyclo-CLLF(CF3)IF(Br) and longer unnatural amino acid linkers. The resulting cyclic peptide PROTACs …
-
Development of Degraders to Target Oncogenic Proteins and Efforts Towards the Total Synthesis of Lycopodium Alkaloids via Oxidative Dearomatization
… (CRC). Guided by crystal structures of SOS1 and cereblon, we designed and synthesized a series of PROTACs based on quinazoline‑linker‑lenalidomide hybrids. Among these, the lead degrader induced up to 92% degradation of SOS1 in CRC cell lines and patient‑derived organoids (PDOs), with excellent …
-
Development of macrocyclic peptides as multifunctional probes in chemical biology
… recruiting either von Hippel Lindau (VHL) or cereblon (CRBN) E3 ligases. KDM4A protein degradation was established in cells transiently overexpressing HaloTagged and Flag tagged KDM4A (HaloFlagKDM4A) using HaloTag targeting PROTACs. Conditions established using HaloPROTACs were used to test …
-
Estudo farmacogenético da resposta ao tratamento do eritema nodoso hansênico
… (2) gene CRBN que codifica a proteína Cereblon, um alvo da teratogenicidade da talidomida e associada ao efeito terapêutico da droga no Mieloma Múltiplo (MM); (3) gene TLR-9 que codifica o receptor toll like receptor 9 (TLR-9), associado ao processo 14 inflamatório do ENH. Na análise de …
-
Virtual Screening for Inhibitors of Anti-apoptotic Proteins: DCK, BCL-XL, MCL-1, MDMX, and MDM2
… to be born limbless. Current thinking is that Cereblon through an unknown teratogenic mechanism activates an increase in FGF8. We suggest a mechanism that may happen in parallel that involves stabilization of MDM2 and the reduction of P63 levels. Chapter 4, the work that was done against the …
-
Developing and Characterising PROTACs against Ser/Thr protein kinase CK1δ/ε
… via alkyl or PEG linkers of varying lengths to cereblon-binding thalidomide/pomalidomide derivatives were employed in cells. Some of these PROTACs degraded CK1δ/ε in various cancer cells at concentrations of 5–10 µM within 6–24 h. The most potent compound reduced CK1δ levels with an average IC₅₀ …
-
Investigating the interaction between Fam83G/PAWS1 and Ser/Thr protein kinase CK1α
… of CK1α, through recruitment of Cullin4A-cereblon E3 ligase complex, also degrade wild type Fam83G but not those mutants that do not interact with CK1α, suggesting co-degradation of Fam83G necessitates interaction with CK1α.
-
Synthesis and Biological Evaluation of Heterobifunctional Small Molecules for Proteasome-Mediated Protein Degradation of Myeloid Cell Leukemia 1 (MCL1)
… of the E3 ubiquitin ligase CUL4A–DDB1 cereblon (CRBN) ubiquitination pathway through rigorous UPS checkpoint validation, making these MCL1 degraders a first step toward a new class of antiapoptotic B-cell lymphoma 2 (BCL2) family protein degraders.
-
Chemical Probes for Translational Research on Monoacylglycerol Lipase
… promote MAGL degradation via the E3 ligase Cereblon. Alternative modalities for investigating MAGL include Raman-active probes, biotin-linked compounds for assay applications, and ligand-directed covalent modifications of MAGL’s lysine side chains. Overall, these probes provide valuable …
-
Discovery of small molecules targeting tumor immune response and tumor cell metastasis
… a library of TIP60 degraders to recruit the Cereblon (CRBN) E3 ubiquitin ligase and promote ligand-induced dimerization of TIP60 and CRBN in cells to degrade TIP60 by the proteasome. By varying linker composition and length, we were able to assess conditions that allow for effective …
-
Interrogation of EpoR Fidelity in Myelodysplastic Syndrome Hematopoiesis and Stabilization by the Immunomodulatory Agent, Lenalidomide
… Subsequent studies showed that LEN inhibits the cereblon E3 ubiquitin ligase complex, the newly discovered target of LEN. Cereblon has been reported to be the principal protein involved in thalidomide induced teratogenicity. Furthermore, the cytotoxic activity of LEN in multiple myeloma is …
Page 1 of 3